Literature DB >> 7308996

Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis.

J Ludwig, S S Barham, N F LaRusso, L R Elveback, R H Wiesner, J T McCall.   

Abstract

Histologic, ultrastructural, chemical, and statistical methods were used to study liver biopsy and autopsy specimens from 43 patients who had primary sclerosing cholangitis (PSC), with or without chronic ulcerative colitis (CUC), and from 19 patients who had CUC without PSC. In all study groups, essentially the same abnormalities were found in the hepatic parenchyma outside the major bile ducts, although nondiagnostic tissue samples were observed also. Specimens from patients with extrahepatic PSC were indistinguishable from those patients with combined extra- and intrahepatic PSC. Common findings included periductal fibrosis and inflammation, portal edema and fibrosis, focal proliferation of bile ducts and ductules, focal bile duct obliteration and loss of bile ducts, copper deposition, and cholestasis. Proliferation of bile ducts in some portal tracts and obliteration or absence of bile duct in others were the most characteristic changes. In most specimens, inflammatory changes appeared mild, yet biliary cirrhosis had developed in 34% of the patients. Specimens from patients with PSC, with or without CUC, more often contained bile and strikingly increased stainable copper (Grades 2 and 3) than did specimens from patients with CUC without PSC. Hepatic copper contents, measured by atomic absorption spectrophotometry, also were higher in specimens from patients with PSC. Study of PCS specimens by transmission electron microscopy and by energy-dispersive X-ray microanalysis revealed that most copper was sequestered in lipolysosomes. The recognition of strikingly similar morphologic features in many liver specimens from patients with either PSC or CUC or both suggests that the causes of these conditions are closely related.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7308996     DOI: 10.1002/hep.1840010612

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  61 in total

1.  Asymptomatic primary sclerosing cholangitis with marked hepatic fibrosis.

Authors:  H Kawai; Y Aoyagi; M Nomoto; H Takizawa; Y Suzuki; A Hama; T Suda; T Takahashi; H Asakura
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

Review 2.  Primary sclerosing cholangitis.

Authors:  S A Mitchell; R W Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

3.  A rare manifestation of idiopathic hypereosinophilic syndrome: sclerosing cholangitis.

Authors:  Isabelle Delèvaux; Marc André; Jacques Chipponi; Anne-Marie Milési-Lecat; P Déchelotte; Olivier Aumaître
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

4.  [Rare initial manifestation and differential diagnosis of primary sclerosing cholangitis].

Authors:  B Rehermann; K Klugewitz; U Seifert; K H Böker; S Wagner; M P Manns
Journal:  Med Klin (Munich)       Date:  1997-07-15

Review 5.  Primary sclerosing cholangitis: updates in diagnosis and therapy.

Authors:  Piero Portincasa; Michele Vacca; Antonio Moschetta; Michele Petruzzelli; Giuseppe Palasciano; Karel J van Erpecum; Gerard P van Berge-Henegouwen
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

6.  Three stages of copper accumulation in hepatocellular lysosomes: X-ray microanalysis of copper-loaded golden hamsters.

Authors:  A Yagi; H Hayashi; T Higuchi; N Hishida; N Sakamoto
Journal:  Int J Exp Pathol       Date:  1992-02       Impact factor: 1.925

7.  Small-duct primary sclerosing cholangitis. A single-center seven-year experience.

Authors:  Nikolaos L Nikolaidis; Olga I Giouleme; Konstantinos A Tziomalos; Kalliopi Patsiaoura; Eirini Kazantzidou; Anastasios D Voutsas; Themistoklis Vassiliadis; Nikolaos P Eugenidis
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

Review 8.  Primary sclerosing cholangitis: diagnosis, prognosis, and management.

Authors:  Siddharth Singh; Jayant A Talwalkar
Journal:  Clin Gastroenterol Hepatol       Date:  2013-02-27       Impact factor: 11.382

9.  Cholangiocarcinoma complicating primary sclerosing cholangitis.

Authors:  C B Rosen; D M Nagorney; R H Wiesner; R J Coffey; N F LaRusso
Journal:  Ann Surg       Date:  1991-01       Impact factor: 12.969

Review 10.  Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.

Authors:  Rebecca Saich; Roger Chapman
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.